The present invention relates to the use of the level of certain cytokines in a patients blood as an objective measure for the purpose of assessing disease progression in patients suffering from Alzheimers disease and for the purpose of determining therapeutic effectiveness of a treatment regimen. Methods for treating Alzheimers disease and monitoring therapeutic effectiveness are provided.
